Updated Date:
12 Oct 2026
Product Detail:
FOLOTYN pralatrexate 20 mg/1 mL injection, intravenous infusion vial
Shortage Status:
Current
AUST R:
192493
Availability:
Unavailable
Active Ingredient:
pralatrexate
Reason:
Manufacturing
Dosage Form:
Injection,intravenousinfusion
Supply Impact Dates
From 12 Oct 2026
To 06 Nov 2026
Management Action:
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals.